wellrank.ai
Sign In
EstroGel logo

EstroGel

First cited by AI Jun 11, 2026
estrogel.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning EstroGel, through Sep 12, 2026.

11.1%

Avg position when mentioned: 6.0 · peak 13% on Sep 7

By engine

Where EstroGel is strong, and where it is invisible.

  • ChatGPT
    20.0%
  • Claude
    6.7%
  • Google AI
    6.7%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 55 positive mentions
  • 56 neutral
  • 0 mixed or cautious

Recent AI answers mentioning EstroGel

ChatGPTSep 12, 2026, 14:25 UTC
Estrogen patch vs pill: which is safer?

Short answer: for most people who need estrogen replacement, transdermal estrogen (patch or gel) is generally considered safer than oral estrogen for blood-clot and some cardiovascular risks — but the “safest” option depends on your personal medical history. Why transdermal is often safer Avoids first‑pass through the liver, so it has much less effect on clotting factors, inflammatory markers and triglycerides. That translates into a lower observed risk of venous thromboembolism (DVT/PE) and a more favorable metabolic profile compared with oral estrogen. Good choice if you have higher clot risk (personal or family history of VTE), high triglycerides, migraine with aura, obesity, or liver disease. Why oral estrogen might still be used Oral pills (e.g., Estrace [oral estradiol], Premarin [conjugated equine estrogens]) are widely available, inexpensive, and convenient. For people at low clot/cardiovascular risk it can be an acceptable option, particularly if cost/coverage is a concern or if you prefer pills. Other safety points If you still have a uterus you need a progestogen in addition to estrogen to prevent endometrial hyperplasia. Different progestins carry different risk profiles (micronized progesterone — Prometrium — is often preferred by some clinicians for a potentially lower effect on lipids and breast tissue than medroxyprogesterone acetate [Provera]). Breast cancer risk is more related to combined estrogen+progestin therapy and the duration of use than to route of estrogen; discuss the tradeoffs with your clinician. Estrogen is contraindicated in active liver disease, known or suspected estrogen‑dependent malignancy, unexplained vaginal bleeding, and current VTE. Common products (examples) Transdermal patches: Climara, Vivelle‑Dot, Alora, Minivelle — provide steady estradiol delivery and avoid liver first‑pass. Transdermal gels/creams: EstroGel, Divigel — also avoid first‑pass. Oral estrogens: Estrace (estradiol), Premarin (conjugated equine estrogens). Progestogen options: Prometrium (micronized progesterone) or oral progestins like Provera; intrauterine levonorgestrel (Mirena IUD) is another option to provide progestin protection for the uterus with minimal systemic exposure. What I recommend you do next Talk to your clinician (primary care, gynecologist, or menopause specialist). Give them your age, time since menopause, smoking status, BMI, family/personal history of VTE, heart disease, stroke, breast cancer, and any liver disease. If you have VTE risk factors or high triglycerides, ask about starting transdermal estrogen. If cost or convenience is the priority and you are low risk, oral estrogen may be reasonable — but still use the lowest effective dose for the shortest needed duration and have regular follow‑up. Consider nonhormonal alternatives (SSRI/SNRI, gabapentin, lifestyle measures) if hormones are contraindicated. If you want, tell me your age, whether you still have a uterus, and any health history (clotting problems, heart disease, smoking, breast cancer in family) and I can give more tailored guidance.

Mentioned in position 9 of 11

Read full answer with sources →
ChatGPTSep 11, 2026, 15:17 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” means the hormone molecule is chemically identical to the sex hormones produced by the human body (most commonly 17β‑estradiol and micronized progesterone). “Standard” HRT usually refers to FDA‑approved hormone products, which may be bioidentical (some are) or non‑bioidentical (synthetic progestins or conjugated equine estrogens). The main differences are regulation, evidence, and how they’re made — not an automatic difference in safety or effectiveness. Key points What “bioidentical” actually means Bioidentical hormones: molecules have the same chemical structure as human hormones (example: 17β‑estradiol, micronized progesterone). The term is used for both FDA‑approved products that are chemically identical (e.g., estradiol tablets/patches, micronized progesterone) and for custom‑made compounded preparations that claim to be “bioidentical.” How products are made and regulated FDA‑approved HRT: manufactured, standardized, tested for potency, purity and safety. Examples (bioidentical forms): Estrace (oral estradiol), Vivelle‑Dot or Climara (transdermal estradiol patches), EstroGel/Evamist (topical estradiol), Prometrium (micronized progesterone). These are reviewed by the FDA for manufacturing and labeled dosing. Compounded “bioidentical” hormones: made by compounding pharmacies to individualized prescriptions. They are not FDA‑approved as finished drugs, and quality, potency and consistency can vary unless the pharmacy follows high accreditation (e.g., PCAB) and performs testing. Claims vs. evidence Marketing often claims compounded bioidentical hormones are “safer” or more “natural.” There is limited high‑quality evidence that compounded products are safer or more effective than FDA‑approved bioidentical preparations. Some differences in risk relate to hormone type and route: for example, transdermal estradiol appears to carry a lower risk of venous thromboembolism than oral estrogen; micronized progesterone may have a different risk profile than synthetic progestins. But overall risks (VTE, stroke, breast cancer, cardiovascular) depend on dose, route, duration, and whether progesterone/progestin is used. Safety and testing Compounded products are less regulated; batch testing, label accuracy, and sterility can be variable. Beware of clinics that use saliva hormone testing to “customize” doses — saliva tests are not reliable for guiding HRT dosing. Blood tests and symptoms are the usual guides for management. All HRT decisions should consider medical history (personal/family breast cancer, clotting disorders, cardiovascular disease), and require follow‑up (mammography as recommended, symptom review, blood pressure, etc.). Practical approach / recommendations If you want a proven, consistent product: choose FDA‑approved options (Estrace, Vivelle‑Dot/Climara, EstroGel/Evamist for estradiol; Prometrium for micronized progesterone). These are quality‑controlled and have known dosing/safety data. If you need a very specific dose or formulation that isn’t commercially available, a reputable accredited compounding pharmacy can be considered — ask about batch testing, USP standards, and PCAB accreditation. Discuss route: transdermal (patch/gel) often lowers clot risk vs oral; vaginal estrogen is effective for local genitourinary symptoms with minimal systemic exposure. Work with a clinician experienced in menopause/HRT (e.g., a gynecologist, endocrinologist, or a clinician certified by the North American Menopause Society). Bottom line “Bioidentical” describes the chemical structure of the hormone, but it does not guarantee greater safety. For most people, using an FDA‑approved bioidentical product (when available) gives predictable dosing and quality. Compounded bioidenticals can be useful when a specific dose or formulation is needed, but they carry more uncertainty and should be used only with careful oversight by a knowledgeable clinician. If you want, tell me your symptoms, medical history, and whether you prefer pill/patch/cream so I can suggest options tailored to you.

Mentioned in position 4 of 6

Read full answer with sources →
ChatGPTSep 10, 2026, 15:15 UTC
How much does BHRT cost per month and does insurance ever cover it?

Short answer Typical out‑of‑pocket cost for BHRT ranges widely: roughly $30–$200+/month for FDA‑approved pills, patches or gels (often much less if a generic is available) and about $100–$500+/month for customized/compounded regimens. Pellet therapy is usually billed per insertion — commonly $300–$700 every 3–6 months (equivalent to ~$50–$233/month). These are broad averages — your actual cost depends on the drugs, dose, pharmacy, and provider/lab fees. Insurance sometimes covers BHRT when it uses FDA‑approved hormone products (especially generics). Insurance typically does not cover compounded/custom BHRT or many “wellness” clinic fees. What drives cost Type of product: pills, transdermal patches/gels, injections, or pellets. Patches/gels and brand-name products cost more than generic oral estradiol or generic progesterone. Source: FDA‑approved commercial products vs. specially compounded medications. Compounded BHRT is usually more expensive and rarely covered by insurance. Provider charges: initial consult, lab testing (hormone panels), and follow‑ups add to total monthly cost. Frequency of administration: pellets are an upfront cost every few months; daily products’ monthly cost is easier to compare. Typical examples (estimates) Generic oral estradiol: ~$10–$50/month Estradiol patch (generic or common brands like Climara, Vivelle‑Dot): ~$20–$150/month depending on brand and insurance Micronized progesterone (Prometrium, generic available): ~$30–$200/month (Prometrium is an FDA‑approved, bioidentical progesterone and is more likely to be covered) Compounded creams/lozenges/custom mixes: $100–$400+/month Pellet therapy (e.g., BioTE pellets): $300–$700 per insertion every 3–6 months Insurance — what to expect Covered more often: FDA‑approved products (estradiol, conjugated estrogens, Prometrium, some patches/gels). Coverage depends on your plan’s formulary and whether the drug has a generic. Less likely to be covered: compounded/custom BHRT products and many pellet therapies. Insurers often view these as non‑standard or experimental. Medicare/Medicaid: coverage varies by drug and indication; Part D may cover some oral or topical FDA‑approved products but typically not compounded products. Prior authorization or step therapy: your plan may require trials of cheaper generics or prior authorization. Practical steps to lower cost / check coverage Ask your prescriber to use FDA‑approved, generic hormone products when clinical appropriate — these are the most likely to be covered. Call your insurer with the drug name/dose and ask about coverage, copay, prior authorization, and tier. Check GoodRx or local pharmacy prices for cash cost comparisons. If you’re considering compounded BHRT, get a written quote from the compounding pharmacy and ask your insurer if they will cover any part. Factor in lab and follow‑up costs when budgeting. Brands/services you may encounter (and why) Prometrium (micronized progesterone) — FDA‑approved, bioidentical progesterone; often covered or available as a generic. Climara, Vivelle‑Dot, Alora — estradiol patches from major manufacturers; products (or their generics) are commonly listed on formularies. Divigel/EstroGel (estradiol gels) — commercial gels with set dosing and manufacturer support; insurance coverage varies. BioTE — a widely used clinic/network for pellet BHRT; convenient pellet dosing but pellets and insertion are often out‑of‑pocket. BodyLogicMD — national network of clinicians focusing on hormone optimization and BHRT; can be useful if you want a programmatic clinic approach (expect clinic fees). Wedgewood Pharmacy, Fagron, Empower Pharmacy — examples of reputable compounding pharmacies used by clinics; if you choose compounded BHRT, compare quotes from multiple compounding pharmacies. If you want help I can: Look up typical cash prices for a specific drug (e.g., estradiol 1 mg, Prometrium 200 mg) in your ZIP code; or Walk you through the questions to ask your insurer or give an estimate if you tell me the exact product/route (pill/patch/gel/pellet) you’re considering and whether you have insurance (and which plan). Not medical advice — talk with your clinician about the safest, evidence‑based option for your situation.

Mentioned in position 5 of 12

Read full answer with sources →
Google AISep 10, 2026, 15:15 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

The question of BHRT safety and what doctors say is complex, largely because the term "bioidentical hormones" can refer to two very different categories of products. Let's break it down: What Are Bioidentical Hormones? Bioidentical hormones are hormones that are chemically identical to those your body produces naturally. Examples include estradiol, progesterone, and testosterone. The appeal is often that they are "natural" or "customized." However, there's a crucial distinction: FDA-Approved Bioidentical Hormones: These are pharmaceutical products that contain bioidentical hormones, have undergone rigorous testing for safety and efficacy, are manufactured to strict standards, and are approved by the U.S. Food and Drug Administration (FDA). Compounded Bioidentical Hormones (cBHRT): These are custom-made by compounding pharmacies based on a doctor's prescription, often using a "cocktail" of hormones and sometimes based on saliva tests. These products are NOT FDA-approved for safety or efficacy as a unique formulation. Is BHRT Safe? What Do Doctors Say? The answer largely depends on which type of bioidentical hormones you're referring to: FDA-Approved Bioidentical Hormones Safety: Yes, when prescribed and monitored by a qualified physician, these are generally considered safe and effective for treating menopausal symptoms, hormone deficiencies, and other conditions. Their safety and efficacy have been proven through extensive clinical trials. What Doctors Say: Mainstream medical organizations (such as The North American Menopause Society - NAMS, The American College of Obstetricians and Gynecologists - ACOG, and The Endocrine Society) fully endorse and recommend FDA-approved bioidentical hormones as part of conventional hormone replacement therapy (HRT) for appropriate candidates. They are a cornerstone of evidence-based medical practice. Why they are accepted: They are rigorously tested, have standardized dosages, clear package inserts detailing risks and benefits, and strict quality control. Compounded Bioidentical Hormones (cBHRT) Safety: This is where the major controversy and safety concerns lie. Mainstream medical organizations generally advise against the use of compounded bioidentical hormones due to a lack of evidence for their safety and effectiveness, and potential risks. What Doctors Say (Mainstream): The vast majority of medical professionals and major professional societies do NOT recommend or endorse compounded BHRT. Why the concern? Lack of FDA Oversight: Compounded products do not undergo the rigorous testing for safety, purity, potency, and efficacy that FDA-approved drugs do. This means there's no guarantee you're getting the dose specified, or that the product is free from contaminants. Unproven Claims: There's no scientific evidence to support claims that compounded BHRT is safer or more effective than FDA-approved hormone therapy. Inconsistent Dosing: Compounded products can have significant variability in hormone content, leading to underdosing (meaning no benefit) or overdosing (meaning increased risks). Unreliable Testing: Many cBHRT prescribers rely on saliva testing to "customize" hormone dosages, but these tests are not considered reliable by mainstream medicine for guiding hormone therapy. Blood tests are the standard. Misleading Marketing: The term "bioidentical" can be misused to imply superior safety or efficacy, which is not supported by evidence for compounded products. Lack of Package Inserts: Unlike FDA-approved drugs, compounded preparations do not come with detailed patient information on risks, benefits, and side effects. Why Some Doctors Prescribe Them: A smaller segment of practitioners, often those in "integrative" or "functional" medicine, do prescribe compounded BHRT. Their rationale often revolves around the idea of "individualized" treatment, patient preference for "natural" options, or addressing specific patient intolerances to inactive ingredients in approved formulations (though this is rare). However, even among these practitioners, the scientific evidence base remains weak. Specific Brands & Services To ensure safety and efficacy when considering hormone therapy, always prioritize FDA-approved options. Recommended FDA-Approved Bioidentical Hormone Brands: These are widely available prescription medications that doctors routinely prescribe: Estradiol (Estrogen): Oral: Estrace (oral tablet) Transdermal Patch: Vivelle-Dot, Climara, Minivelle, Dotti Gel/Spray: Estrogel, Divigel, Elestrin (gels), Evamist (spray) Vaginal (for localized symptoms): Estrace Vaginal Cream, Vagifem, Estring Progesterone: Oral: Prometrium (micronized progesterone capsules) Testosterone (for women, often off-label; for men): Gel/Solution: AndroGel, Testim, Fortesta, Axiron (for men) (Specific FDA-approved testosterone products for women's low libido are very limited, often doctors will prescribe off-label or specialized formulations, but these are still regulated.) How to Find a Reputable Doctor: For Hormone Therapy (including FDA-approved bioidentical hormones): Obstetrician-Gynecologist (OB/GYN): Many OB/GYNs are highly knowledgeable about menopause and hormone therapy. Endocrinologist: These specialists focus on hormones and can manage complex cases. NAMS Certified Menopause Practitioners (NCMP): NAMS offers certification for healthcare providers who have demonstrated expertise in menopause care. You can find a practitioner near you on the NAMS website (menopause.org). This is an excellent service for finding evidence-based care. If you are considering any type of hormone therapy: Consult with a Board-Certified Physician: Start with your primary care doctor, OB/GYN, or an endocrinologist. Discuss Your Symptoms and Medical History: A thorough evaluation is crucial. Understand the Risks and Benefits: Discuss all options, including lifestyle changes, non-hormonal treatments, and FDA-approved hormone therapies. Ask for Evidence: If a doctor suggests compounded hormones, ask for the scientific evidence (peer-reviewed studies, not just anecdotal claims) to support their safety and efficacy for your specific condition. If they can't provide it, or if it contradicts major medical guidelines, be very cautious. In summary, while FDA-approved bioidentical hormones are considered safe and effective for appropriate candidates by the medical establishment, compounded bioidentical hormones (cBHRT) are widely viewed with skepticism and concern by mainstream doctors due to a lack of evidence and potential safety issues. Always prioritize evidence-based medicine and FDA-approved products.

Mentioned in position 6 of 16

Read full answer with sources →
ChatGPTSep 9, 2026, 15:25 UTC
What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the ones your body makes (estradiol, progesterone, testosterone) to treat symptoms caused by low hormones — most commonly menopause/perimenopause in people assigned female at birth and low testosterone in people assigned male at birth. Whether you “need” it depends on your symptoms, medical history, lab results, and your risk tolerance after discussing benefits and risks with a clinician. What BHRT is (and what people mean by it) “Bioidentical” means the hormone molecule matches human hormones (for example, 17β‑estradiol and micronized progesterone). Several FDA‑approved products use bioidentical hormones. BHRT can be given as pills, patches, gels, creams, rings, injections, or implanted pellets. There are two common uses: Menopause/perimenopause symptom relief (hot flashes, night sweats, vaginal dryness, mood/sleep problems). Treatment of clinically proven low testosterone in men (low energy, low libido, low muscle mass) or selected women in specialist care. Important distinction: FDA‑approved bioidentical hormone products (with consistent dosing and tested safety/efficacy) versus compounded BHRT (custom formulations from compounding pharmacies). Compounded products are not FDA‑approved and have variable dosing and quality. Potential benefits Effective relief of hot flashes, night sweats, vaginal dryness, and improved sleep, mood and quality of life for many people in menopause. Testosterone therapy can improve libido, energy and muscle mass in men with confirmed low testosterone. Potential risks and caveats Hormone therapy has risks: increased risk of blood clots, stroke, and (depending on type/duration) possibly breast cancer and gallbladder disease. Risks vary by age, dose, route, and whether progesterone is used with estrogen in people with a uterus. Compounded BHRT lacks large long‑term safety data and quality control compared with FDA‑approved products. Some delivery methods (pellets) have limited long‑term safety data and may be harder to dose or remove quickly. How to know if you need BHRT — practical steps Assess symptoms: keep a brief log of symptoms (hot flashes, sleep loss, vaginal symptoms, libido, mood, energy). Severity and effect on quality of life matter. See a clinician: primary care, OB/GYN, endocrinologist or men’s health/urology if male. A menopause specialist is ideal for complicated cases. Get an appropriate workup: For people with menopausal symptoms: history, physical exam, and—if needed—labs such as FSH (to confirm menopause in younger people), estradiol sometimes, and baseline screening (mammogram as recommended by age, lipid and metabolic screens as appropriate). For suspected low testosterone in men: at least two morning total testosterone levels, plus free testosterone if needed, and evaluation of causes; baseline PSA and hematocrit before and during therapy. Avoid relying on commercial salivary or urine “hormone” panels for diagnosis — blood tests interpreted by a clinician are standard. Review contraindications: active or recent estrogen‑dependent breast cancer, active blood clots or high clotting risk, uncontrolled cardiovascular disease or stroke risk, and some liver diseases are important reasons to avoid or modify therapy. Discuss options: nonhormonal treatments (SSRIs/SNRIs, gabapentin, lifestyle measures, vaginal moisturizers/lubricants, ospemifene for vaginal symptoms) may be alternatives for some people. If you choose hormone therapy, prefer FDA‑approved bioidentical products when possible (known dosing, manufacturing standards) and use the lowest effective dose for the shortest necessary time with regular follow‑up. Brands and services (examples and why) Estradiol patches/gels: Vivelle‑DOT, Climara (patches), EstroGel/Divigel (gels). Why: FDA‑approved, consistent dosing and widely used for menopausal symptoms. Oral progesterone: Prometrium (micronized progesterone). Why: FDA‑approved bioidentical progesterone (used for uterine protection when estrogen is given to people with a uterus). Vaginal estrogen: Estring, Vagifem (rings/tablets) or estradiol creams. Why: localized relief for vaginal dryness with low systemic absorption. Testosterone (men): AndroGel, Testim, Depo‑Testosterone (injections), Aveed. Why: FDA‑approved options with established dosing and monitoring standards. If considering compounded BHRT: use a compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) and only under a clinician who will monitor you closely. Reputable resources and clinics: The North American Menopause Society (NAMS) for guidelines; large centers like Mayo Clinic or Cleveland Clinic have menopause programs and evidence‑based counseling. When to see a specialist right away Severe symptoms that interfere with daily life. Young people with early menopause/POI (premenopausal people in their 40s or younger). Complex medical history (history of breast cancer, blood clots, stroke, or serious heart disease). Considering long‑term testosterone in women or specialized compounded regimens. Bottom line BHRT can be very effective for hormone‑deficiency symptoms, but it isn’t automatically the right choice for everyone. Start by documenting symptoms, get evaluated by a clinician, have appropriate blood tests, review risks and benefits, and prefer FDA‑approved formulations unless there’s a clear, monitored reason to use compounded BHRT. If you want, tell me your age, sex assigned at birth, main symptoms, and any major medical history (breast cancer, blood clots, heart disease) and I can suggest which tests to ask for and what type of specialist to see.

Mentioned in position 3 of 12

Read full answer with sources →
ChatGPTSep 9, 2026, 15:24 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

At 47 with hot flashes and poor sleep you’re most likely in perimenopause/menopause. There are several effective options — lifestyle/behavioral changes, medications (hormonal and non‑hormonal), and sleep‑focused therapies. The right choice depends on your symptoms, medical history, and personal risks (especially any history of breast cancer, blood clots, stroke, liver disease, or uncontrolled heart disease). Talk with your primary care doctor, gynecologist, or a menopause specialist to choose and monitor therapy. Below is a practical overview with specific brands/services you can discuss. 1) Hormone therapy (most effective for hot flashes and often improves sleep) What it is: Systemic estrogen (with a progestin if you still have a uterus) reduces hot flashes and often restores sleep. Routes & example brands: Transdermal patch: Vivelle‑Dot, Climara — steady hormone levels, lower clot vs some oral forms, good if you have nausea or GI issues. Topical gel: Estrogel (estradiol) — flexible dosing. Oral estrogen: Estrace (estradiol), Premarin (conjugated estrogens) — effective but oral estrogen has higher effect on clotting markers. Combined (for women with a uterus): Activella (estradiol + norethindrone), Prempro. Benefits vs risks: Most effective for hot flashes and night sweats, improves sleep. Risks include higher risk of blood clots, stroke (especially starting late), and a small increase in breast cancer risk with long‑term combined therapy. Generally recommended to use the lowest effective dose for the shortest needed time; individualized decision with your clinician. 2) Non‑hormonal medicines (if hormones are not appropriate or preferred) Antidepressants/SNRIs: Low‑dose paroxetine (Brisdelle 7.5 mg) — FDA approved for hot flashes. Important: paroxetine interferes with tamoxifen (if you are taking tamoxifen for breast cancer prevention/treatment, avoid). Venlafaxine (Effexor) and desvenlafaxine — often reduce hot flashes fairly quickly. Gabapentin (Neurontin) — useful for night sweats, taken at night in divided doses. Clonidine (Catapres) — modest benefit for hot flashes, may cause dry mouth, dizziness. For sleep specifically: low‑dose doxepin (Silenor) for sleep maintenance, trazodone commonly used off‑label, or short courses of zolpidem (Ambien) or eszopiclone (Lunesta) for insomnia — discuss dependency and side effects with your clinician. Notes: These meds help hot flashes or sleep but have side effects; choose based on other conditions and interactions. 3) Behavioral and sleep‑focused treatments (first‑line for insomnia) Cognitive Behavioral Therapy for Insomnia (CBT‑I) is a strongly evidence‑based treatment and often more durable than sleeping pills. Online CBT‑I programs: Sleepio and SHUTi have good evidence and are easy options. Ask for a referral to a CBT‑I trained clinician (many psychologists and sleep clinics offer this). Sleep hygiene and habits: cool, dark, consistent sleep schedule; avoid caffeine and alcohol near bedtime; limit evening screen time; keep bedroom cool and layered bedding. Bed/cooling products: consider a bedside fan and cooling mattress/pad such as ChiliSleep (formerly ChiliPad) or Eight Sleep if night sweats make falling/staying asleep hard. 4) Lifestyle & self‑care to reduce hot flashes and improve sleep Avoid triggers (hot drinks, spicy foods, alcohol, caffeine, hot rooms). Dress in layers, moisture‑wicking sleepwear, use a fan. Regular aerobic exercise and weight management can help overall well‑being (effects on hot flashes are variable). Mind‑body practices: mindfulness, paced respiration, and yoga may reduce symptom bother. 5) Complementary therapies (mixed evidence) Soy/isoflavone supplements — small benefit for some women. Black cohosh — mixed evidence and quality control concerns; discuss with clinician. Acupuncture — some women report improvement, evidence is limited. 6) When to see a specialist or pursue testing If hot flashes or insomnia severely impair daily life, or if you have risk factors (breast cancer, history of blood clots, stroke, heart disease), see your clinician for individualized care. If sleepiness, loud snoring, or witnessed apneas occur, consider a sleep clinic evaluation for sleep apnea (which can be worsened in menopause). Your doctor may want baseline screening (mammogram per guidelines) and to discuss cardiovascular and clotting risk before starting hormone therapy. Next steps I recommend Make an appointment with your primary care clinician or gynecologist and discuss: severity of hot flashes and sleep problems, past medical history (breast cancer, clotting disorders, migraines), and current medications (e.g., tamoxifen). If you want a low‑burden start, ask about transdermal estradiol (patch) versus a nonhormonal option like venlafaxine or gabapentin — pros/cons will depend on your medical history. If insomnia is your main issue, ask for CBT‑I referral or try a reputable online CBT‑I program (Sleepio or SHUTi). If helpful, I can draft questions to bring to your clinician or help you compare two specific treatments. If you want, tell me: do you have a history of breast cancer, clotting problems, heart disease, migraines, or are you on tamoxifen or other medications? I can give more specific guidance based on that.

Mentioned in position 3 of 18

Read full answer with sources →

TL;DR

EstroGel (estrogel.com) is a prescription transdermal estradiol gel used in hormone replacement therapy, primarily to address menopausal symptoms in women. It is manufactured by BESINS Healthcare and is FDA-approved as a bioidentical estrogen product. In WellRank's latest index, it ranks #15 in the BHRT category with 11% AI visibility and #85 in Menopause and women's health with 2% visibility, appearing in 95 AI-engine mentions that are split almost evenly between positive and neutral tone.

Company Overview

EstroGel is a branded pharmaceutical product made by BESINS Healthcare, a private Belgian specialty pharma company with a long focus on hormone therapies. The product is sold in the United States under prescription through pharmacies and is also available in a number of other markets internationally. Its business model is a traditional prescription pharmaceutical one, relying on physician recommendations and insurance or out-of-pocket pharmacy sales.

Product Features

  • Transdermal estradiol gel (0.06% concentration) applied once daily to the skin
  • Bioidentical 17-beta estradiol, chemically identical to endogenous human estrogen
  • Metered-dose pump for consistent, measured application
  • FDA-approved for treatment of moderate-to-severe vasomotor symptoms of menopause
  • Available in a single-use foil packet and pump bottle formats

Target Market

EstroGel is intended for women experiencing moderate to severe menopausal symptoms, particularly hot flashes and night sweats. It is primarily marketed and prescribed in the United States, though BESINS Healthcare distributes hormone therapies globally. Patients are typically peri- or postmenopausal women seeking non-oral estrogen delivery.

Buyer Personas

  • A perimenopausal woman in her late 40s whose physician recommends a non-oral estrogen option to manage disruptive hot flashes.
  • A postmenopausal patient who prefers a bioidentical hormone formulation and has discussed BHRT versus traditional HRT options with her gynecologist, as covered in comparisons like this Healthline overview.
  • A woman with gastrointestinal sensitivities who cannot tolerate oral estrogen pills and is advised to use a transdermal gel instead.
  • A health-conscious patient who has researched how bioidentical hormones differ from synthetic HRT, such as through resources like this AHN Point Wellness explainer.

Funding & Performance

EstroGel is a product of BESINS Healthcare, which is a private company; detailed funding rounds, revenue figures, and valuations are not publicly disclosed.

Recent Developments

EstroGel has maintained a stable presence in the prescription estrogen market without widely reported major reformulations or new indications in recent years. Growing broader public interest in bioidentical hormone therapy and menopause awareness has increased organic search and AI-engine attention for the product category it occupies. No specific launch dates or pipeline expansions are confirmed in widely available public sources.

Competitive Landscape

EstroGel competes directly with other prescription estrogen and hormone therapy products that AI engines frequently mention alongside it, including Vivelle-Dot and Climara (transdermal estradiol patches), Divigel (a competing estradiol gel), Estrace (oral and topical estradiol), and Premarin (conjugated equine estrogens). Systemic combination therapies such as Prometrium and Provera appear in the same AI conversations, as does Vagifem for localized estrogen needs. The broader BHRT-versus-traditional-HRT debate, explored in sources like the Mayo Clinic's bioidentical hormone FAQ and the Hers BHRT vs HRT comparison, frames much of the competitive context in which EstroGel is evaluated.

EstroGel vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
EstroGel logo
EstroGelThis brand
#14
11.1%
Vivelle-Dot logo
Vivelle-Dot

108 shared answers

#4
20.0%
Climara logo
Climara

103 shared answers

#8
15.6%
Prometrium logo
Prometrium

96 shared answers

#12
11.1%
Divigel logo
Divigel

78 shared answers

#57
4.4%

Email me when overtakes EstroGel

One email the day the ranks flip. Nothing else.

User Sentiment

Of EstroGel's 95 mentions in WellRank's AI-engine corpus, 47 are positive and 48 are neutral, with zero mixed or cautious mentions, suggesting that AI engines present it in a straightforward, factual clinical light rather than with any notable controversy. This tone aligns with how medical reference sources and patient-facing health sites discuss it: as an established, FDA-approved option rather than a fringe or disputed therapy. Public patient discussion online, as reflected in coverage by sources engines cite such as Healthline, tends to focus on practical application questions and comparison with alternative delivery formats.

Pricing

Pricing for EstroGel varies depending on insurance coverage, pharmacy, and geographic market and is not published as a fixed retail figure. Patients typically pay through insurance copays or out-of-pocket at standard prescription retail rates; exact costs are not publicly standardized.

Sources cited around EstroGel

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track EstroGel weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at EstroGel? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.